nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Betaxolol—glaucoma	0.118	0.247	CbGbCtD
Imiquimod—CYP3A4—Pilocarpine—glaucoma	0.0691	0.145	CbGbCtD
Imiquimod—CYP1A2—Clonidine—glaucoma	0.0645	0.135	CbGbCtD
Imiquimod—CYP3A4—Brinzolamide—glaucoma	0.0543	0.114	CbGbCtD
Imiquimod—CYP3A4—Dorzolamide—glaucoma	0.0524	0.11	CbGbCtD
Imiquimod—CYP3A4—Methazolamide—glaucoma	0.0467	0.0982	CbGbCtD
Imiquimod—CYP3A4—Acetazolamide—glaucoma	0.0373	0.0785	CbGbCtD
Imiquimod—CYP3A4—Clonidine—glaucoma	0.0338	0.071	CbGbCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TBK1—glaucoma	0.00322	0.0759	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TBK1—glaucoma	0.00251	0.0593	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TBK1—glaucoma	0.00248	0.0586	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TBK1—glaucoma	0.00244	0.0575	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TBK1—glaucoma	0.0019	0.0449	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TBK1—glaucoma	0.00188	0.0444	CbGpPWpGaD
Imiquimod—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.00136	0.0322	CbGpPWpGaD
Imiquimod—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000937	0.0221	CbGpPWpGaD
Imiquimod—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000853	0.0201	CbGpPWpGaD
Imiquimod—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000834	0.0197	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TXNIP—glaucoma	0.00082	0.0194	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TBK1—glaucoma	0.000804	0.019	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—C1QB—glaucoma	0.000727	0.0172	CbGpPWpGaD
Imiquimod—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000658	0.0155	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TXN—glaucoma	0.000648	0.0153	CbGpPWpGaD
Imiquimod—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000643	0.0152	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000636	0.015	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TXNIP—glaucoma	0.000621	0.0147	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TBK1—glaucoma	0.000609	0.0144	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CTSA—glaucoma	0.000567	0.0134	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—C1QB—glaucoma	0.000551	0.013	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TXN—glaucoma	0.000491	0.0116	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.00049	0.0116	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.000487	0.0115	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TXNIP—glaucoma	0.000478	0.0113	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TBK1—glaucoma	0.000468	0.0111	CbGpPWpGaD
Imiquimod—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000433	0.0102	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CTSA—glaucoma	0.00043	0.0102	CbGpPWpGaD
Imiquimod—TLR8—Immune System—C1QB—glaucoma	0.000424	0.01	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000392	0.00924	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	0.00038	0.00898	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000378	0.00892	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TXN—glaucoma	0.000378	0.00891	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.000369	0.00872	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TXNIP—glaucoma	0.000362	0.00854	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TBK1—glaucoma	0.000355	0.00838	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000334	0.0079	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000334	0.00789	CbGpPWpGaD
Imiquimod—TLR7—Immune System—C1QB—glaucoma	0.000321	0.00758	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000302	0.00713	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000295	0.00695	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	0.000288	0.00681	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TXN—glaucoma	0.000286	0.00675	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—C3—glaucoma	0.000283	0.00668	CbGpPWpGaD
Imiquimod—Decreased appetite—Brinzolamide—glaucoma	0.000271	0.000563	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—BCL2L1—glaucoma	0.000271	0.00639	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000271	0.00639	CbGpPWpGaD
Imiquimod—Pain—Travoprost—glaucoma	0.00027	0.000561	CcSEcCtD
Imiquimod—Agitation—Clonidine—glaucoma	0.00027	0.00056	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00027	0.000559	CcSEcCtD
Imiquimod—Paraesthesia—Pilocarpine—glaucoma	0.000269	0.000559	CcSEcCtD
Imiquimod—Asthenia—Bimatoprost—glaucoma	0.000269	0.000559	CcSEcCtD
Imiquimod—Fatigue—Brinzolamide—glaucoma	0.000269	0.000559	CcSEcCtD
Imiquimod—Angioedema—Clonidine—glaucoma	0.000268	0.000557	CcSEcCtD
Imiquimod—Dyspnoea—Pilocarpine—glaucoma	0.000268	0.000555	CcSEcCtD
Imiquimod—Pain—Brinzolamide—glaucoma	0.000267	0.000554	CcSEcCtD
Imiquimod—Somnolence—Pilocarpine—glaucoma	0.000267	0.000554	CcSEcCtD
Imiquimod—Depression—Timolol—glaucoma	0.000266	0.000553	CcSEcCtD
Imiquimod—Angiopathy—Betaxolol—glaucoma	0.000266	0.000553	CcSEcCtD
Imiquimod—Pruritus—Bimatoprost—glaucoma	0.000266	0.000551	CcSEcCtD
Imiquimod—Immune system disorder—Betaxolol—glaucoma	0.000265	0.00055	CcSEcCtD
Imiquimod—Diarrhoea—Apraclonidine—glaucoma	0.000265	0.00055	CcSEcCtD
Imiquimod—Malaise—Clonidine—glaucoma	0.000265	0.000549	CcSEcCtD
Imiquimod—Mediastinal disorder—Betaxolol—glaucoma	0.000265	0.000549	CcSEcCtD
Imiquimod—Dyspepsia—Pilocarpine—glaucoma	0.000264	0.000548	CcSEcCtD
Imiquimod—Chills—Betaxolol—glaucoma	0.000264	0.000547	CcSEcCtD
Imiquimod—Syncope—Clonidine—glaucoma	0.000263	0.000546	CcSEcCtD
Imiquimod—Arrhythmia—Betaxolol—glaucoma	0.000262	0.000544	CcSEcCtD
Imiquimod—Feeling abnormal—Dorzolamide—glaucoma	0.000262	0.000543	CcSEcCtD
Imiquimod—Decreased appetite—Pilocarpine—glaucoma	0.000261	0.000541	CcSEcCtD
Imiquimod—Feeling abnormal—Travoprost—glaucoma	0.000261	0.000541	CcSEcCtD
Imiquimod—Conjunctivitis—Timolol—glaucoma	0.00026	0.000539	CcSEcCtD
Imiquimod—Gastrointestinal pain—Dorzolamide—glaucoma	0.00026	0.000539	CcSEcCtD
Imiquimod—Alopecia—Betaxolol—glaucoma	0.00026	0.000538	CcSEcCtD
Imiquimod—Palpitations—Clonidine—glaucoma	0.00026	0.000538	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000259	0.000538	CcSEcCtD
Imiquimod—Gastrointestinal pain—Travoprost—glaucoma	0.000259	0.000537	CcSEcCtD
Imiquimod—Loss of consciousness—Clonidine—glaucoma	0.000258	0.000536	CcSEcCtD
Imiquimod—Feeling abnormal—Brinzolamide—glaucoma	0.000257	0.000534	CcSEcCtD
Imiquimod—Mental disorder—Betaxolol—glaucoma	0.000257	0.000534	CcSEcCtD
Imiquimod—Pain—Pilocarpine—glaucoma	0.000257	0.000533	CcSEcCtD
Imiquimod—Cough—Clonidine—glaucoma	0.000256	0.000532	CcSEcCtD
Imiquimod—Dizziness—Apraclonidine—glaucoma	0.000256	0.000532	CcSEcCtD
Imiquimod—Erythema—Betaxolol—glaucoma	0.000256	0.00053	CcSEcCtD
Imiquimod—Malnutrition—Betaxolol—glaucoma	0.000256	0.00053	CcSEcCtD
Imiquimod—Urticaria—Dorzolamide—glaucoma	0.000252	0.000524	CcSEcCtD
Imiquimod—Body temperature increased—Dorzolamide—glaucoma	0.000251	0.000521	CcSEcCtD
Imiquimod—Abdominal pain—Dorzolamide—glaucoma	0.000251	0.000521	CcSEcCtD
Imiquimod—Sinusitis—Timolol—glaucoma	0.000251	0.00052	CcSEcCtD
Imiquimod—Chest pain—Clonidine—glaucoma	0.00025	0.000519	CcSEcCtD
Imiquimod—Arthralgia—Clonidine—glaucoma	0.00025	0.000519	CcSEcCtD
Imiquimod—Abdominal pain—Travoprost—glaucoma	0.00025	0.000519	CcSEcCtD
Imiquimod—Anxiety—Clonidine—glaucoma	0.000249	0.000517	CcSEcCtD
Imiquimod—Asthenia—Acetazolamide—glaucoma	0.000249	0.000516	CcSEcCtD
Imiquimod—Dizziness—Bimatoprost—glaucoma	0.000248	0.000515	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000248	0.000515	CcSEcCtD
Imiquimod—Urticaria—Brinzolamide—glaucoma	0.000248	0.000515	CcSEcCtD
Imiquimod—Feeling abnormal—Pilocarpine—glaucoma	0.000247	0.000513	CcSEcCtD
Imiquimod—Discomfort—Clonidine—glaucoma	0.000247	0.000513	CcSEcCtD
Imiquimod—Vomiting—Apraclonidine—glaucoma	0.000246	0.000511	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—BAD—glaucoma	0.000245	0.00579	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Pilocarpine—glaucoma	0.000245	0.000509	CcSEcCtD
Imiquimod—Hypersensitivity—Brimonidine—glaucoma	0.000245	0.000508	CcSEcCtD
Imiquimod—Dry mouth—Clonidine—glaucoma	0.000245	0.000507	CcSEcCtD
Imiquimod—Dermatitis—Apraclonidine—glaucoma	0.000244	0.000506	CcSEcCtD
Imiquimod—Headache—Apraclonidine—glaucoma	0.000243	0.000504	CcSEcCtD
Imiquimod—Rhinitis—Timolol—glaucoma	0.000241	0.000499	CcSEcCtD
Imiquimod—Oedema—Clonidine—glaucoma	0.00024	0.000497	CcSEcCtD
Imiquimod—Asthenia—Brimonidine—glaucoma	0.000239	0.000495	CcSEcCtD
Imiquimod—Infection—Clonidine—glaucoma	0.000238	0.000494	CcSEcCtD
Imiquimod—Abdominal pain—Pilocarpine—glaucoma	0.000237	0.000492	CcSEcCtD
Imiquimod—Body temperature increased—Pilocarpine—glaucoma	0.000237	0.000492	CcSEcCtD
Imiquimod—Ill-defined disorder—Betaxolol—glaucoma	0.000237	0.000492	CcSEcCtD
Imiquimod—Diarrhoea—Acetazolamide—glaucoma	0.000237	0.000492	CcSEcCtD
Imiquimod—Rash—Bimatoprost—glaucoma	0.000237	0.000491	CcSEcCtD
Imiquimod—Dermatitis—Bimatoprost—glaucoma	0.000237	0.000491	CcSEcCtD
Imiquimod—Shock—Clonidine—glaucoma	0.000236	0.000489	CcSEcCtD
Imiquimod—Connective tissue disorder—Timolol—glaucoma	0.000236	0.000489	CcSEcCtD
Imiquimod—Pruritus—Brimonidine—glaucoma	0.000235	0.000488	CcSEcCtD
Imiquimod—Headache—Bimatoprost—glaucoma	0.000235	0.000488	CcSEcCtD
Imiquimod—Nervous system disorder—Clonidine—glaucoma	0.000235	0.000488	CcSEcCtD
Imiquimod—Hypersensitivity—Dorzolamide—glaucoma	0.000234	0.000486	CcSEcCtD
Imiquimod—Tachycardia—Clonidine—glaucoma	0.000234	0.000485	CcSEcCtD
Imiquimod—Hypersensitivity—Travoprost—glaucoma	0.000233	0.000483	CcSEcCtD
Imiquimod—Skin disorder—Clonidine—glaucoma	0.000233	0.000483	CcSEcCtD
Imiquimod—Hyperhidrosis—Clonidine—glaucoma	0.000232	0.000481	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000231	0.00546	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000231	0.00546	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000231	0.00546	CbGpPWpGaD
Imiquimod—Visual impairment—Timolol—glaucoma	0.000231	0.00048	CcSEcCtD
Imiquimod—Malaise—Betaxolol—glaucoma	0.000231	0.000478	CcSEcCtD
Imiquimod—Nausea—Apraclonidine—glaucoma	0.00023	0.000477	CcSEcCtD
Imiquimod—Hypersensitivity—Brinzolamide—glaucoma	0.00023	0.000477	CcSEcCtD
Imiquimod—Syncope—Betaxolol—glaucoma	0.000229	0.000476	CcSEcCtD
Imiquimod—Dizziness—Acetazolamide—glaucoma	0.000229	0.000475	CcSEcCtD
Imiquimod—Anorexia—Clonidine—glaucoma	0.000228	0.000474	CcSEcCtD
Imiquimod—Asthenia—Dorzolamide—glaucoma	0.000228	0.000473	CcSEcCtD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000227	0.00537	CbGpPWpGaD
Imiquimod—Asthenia—Travoprost—glaucoma	0.000227	0.000471	CcSEcCtD
Imiquimod—Palpitations—Betaxolol—glaucoma	0.000226	0.000469	CcSEcCtD
Imiquimod—Pruritus—Dorzolamide—glaucoma	0.000225	0.000466	CcSEcCtD
Imiquimod—Loss of consciousness—Betaxolol—glaucoma	0.000225	0.000466	CcSEcCtD
Imiquimod—Eye disorder—Timolol—glaucoma	0.000224	0.000465	CcSEcCtD
Imiquimod—Asthenia—Brinzolamide—glaucoma	0.000224	0.000465	CcSEcCtD
Imiquimod—Pruritus—Travoprost—glaucoma	0.000224	0.000464	CcSEcCtD
Imiquimod—Tinnitus—Timolol—glaucoma	0.000224	0.000464	CcSEcCtD
Imiquimod—Cough—Betaxolol—glaucoma	0.000223	0.000463	CcSEcCtD
Imiquimod—Nausea—Bimatoprost—glaucoma	0.000223	0.000463	CcSEcCtD
Imiquimod—Hypersensitivity—Pilocarpine—glaucoma	0.000221	0.000459	CcSEcCtD
Imiquimod—Pruritus—Brinzolamide—glaucoma	0.000221	0.000458	CcSEcCtD
Imiquimod—Vomiting—Acetazolamide—glaucoma	0.00022	0.000457	CcSEcCtD
Imiquimod—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.00022	0.00519	CbGpPWpGaD
Imiquimod—Dizziness—Brimonidine—glaucoma	0.00022	0.000456	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Clonidine—glaucoma	0.000218	0.000453	CcSEcCtD
Imiquimod—Angiopathy—Timolol—glaucoma	0.000218	0.000452	CcSEcCtD
Imiquimod—Myalgia—Betaxolol—glaucoma	0.000218	0.000452	CcSEcCtD
Imiquimod—Chest pain—Betaxolol—glaucoma	0.000218	0.000452	CcSEcCtD
Imiquimod—Arthralgia—Betaxolol—glaucoma	0.000218	0.000452	CcSEcCtD
Imiquimod—Diarrhoea—Dorzolamide—glaucoma	0.000217	0.000451	CcSEcCtD
Imiquimod—Headache—Acetazolamide—glaucoma	0.000217	0.00045	CcSEcCtD
Imiquimod—Anxiety—Betaxolol—glaucoma	0.000217	0.00045	CcSEcCtD
Imiquimod—Insomnia—Clonidine—glaucoma	0.000217	0.00045	CcSEcCtD
Imiquimod—Immune system disorder—Timolol—glaucoma	0.000217	0.00045	CcSEcCtD
Imiquimod—Diarrhoea—Travoprost—glaucoma	0.000216	0.000449	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000216	0.00511	CbGpPWpGaD
Imiquimod—Mediastinal disorder—Timolol—glaucoma	0.000216	0.000449	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000216	0.000449	CcSEcCtD
Imiquimod—Asthenia—Pilocarpine—glaucoma	0.000215	0.000447	CcSEcCtD
Imiquimod—Paraesthesia—Clonidine—glaucoma	0.000215	0.000447	CcSEcCtD
Imiquimod—Discomfort—Betaxolol—glaucoma	0.000215	0.000446	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—C3—glaucoma	0.000214	0.00506	CbGpPWpGaD
Imiquimod—Arrhythmia—Timolol—glaucoma	0.000214	0.000445	CcSEcCtD
Imiquimod—Dyspnoea—Clonidine—glaucoma	0.000214	0.000443	CcSEcCtD
Imiquimod—Diarrhoea—Brinzolamide—glaucoma	0.000214	0.000443	CcSEcCtD
Imiquimod—Somnolence—Clonidine—glaucoma	0.000213	0.000442	CcSEcCtD
Imiquimod—Dry mouth—Betaxolol—glaucoma	0.000213	0.000442	CcSEcCtD
Imiquimod—Pruritus—Pilocarpine—glaucoma	0.000212	0.000441	CcSEcCtD
Imiquimod—Alopecia—Timolol—glaucoma	0.000212	0.00044	CcSEcCtD
Imiquimod—Mental disorder—Timolol—glaucoma	0.00021	0.000436	CcSEcCtD
Imiquimod—Dizziness—Dorzolamide—glaucoma	0.00021	0.000436	CcSEcCtD
Imiquimod—Rash—Brimonidine—glaucoma	0.00021	0.000435	CcSEcCtD
Imiquimod—Dermatitis—Brimonidine—glaucoma	0.000209	0.000435	CcSEcCtD
Imiquimod—Dizziness—Travoprost—glaucoma	0.000209	0.000434	CcSEcCtD
Imiquimod—Malnutrition—Timolol—glaucoma	0.000209	0.000433	CcSEcCtD
Imiquimod—Erythema—Timolol—glaucoma	0.000209	0.000433	CcSEcCtD
Imiquimod—Oedema—Betaxolol—glaucoma	0.000209	0.000433	CcSEcCtD
Imiquimod—Headache—Brimonidine—glaucoma	0.000208	0.000432	CcSEcCtD
Imiquimod—Decreased appetite—Clonidine—glaucoma	0.000208	0.000432	CcSEcCtD
Imiquimod—Infection—Betaxolol—glaucoma	0.000207	0.00043	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Clonidine—glaucoma	0.000207	0.000429	CcSEcCtD
Imiquimod—Fatigue—Clonidine—glaucoma	0.000207	0.000429	CcSEcCtD
Imiquimod—Dizziness—Brinzolamide—glaucoma	0.000206	0.000428	CcSEcCtD
Imiquimod—Nausea—Acetazolamide—glaucoma	0.000206	0.000427	CcSEcCtD
Imiquimod—Diarrhoea—Pilocarpine—glaucoma	0.000205	0.000426	CcSEcCtD
Imiquimod—Shock—Betaxolol—glaucoma	0.000205	0.000426	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—BCL2L1—glaucoma	0.000205	0.00485	CbGpPWpGaD
Imiquimod—Pain—Clonidine—glaucoma	0.000205	0.000425	CcSEcCtD
Imiquimod—Nervous system disorder—Betaxolol—glaucoma	0.000205	0.000425	CcSEcCtD
Imiquimod—Tachycardia—Betaxolol—glaucoma	0.000204	0.000423	CcSEcCtD
Imiquimod—Skin disorder—Betaxolol—glaucoma	0.000203	0.000421	CcSEcCtD
Imiquimod—Vomiting—Dorzolamide—glaucoma	0.000202	0.000419	CcSEcCtD
Imiquimod—Hyperhidrosis—Betaxolol—glaucoma	0.000202	0.000419	CcSEcCtD
Imiquimod—Rash—Dorzolamide—glaucoma	0.0002	0.000416	CcSEcCtD
Imiquimod—Dermatitis—Dorzolamide—glaucoma	0.0002	0.000415	CcSEcCtD
Imiquimod—Rash—Travoprost—glaucoma	0.000199	0.000414	CcSEcCtD
Imiquimod—Dermatitis—Travoprost—glaucoma	0.000199	0.000413	CcSEcCtD
Imiquimod—Headache—Dorzolamide—glaucoma	0.000199	0.000413	CcSEcCtD
Imiquimod—Anorexia—Betaxolol—glaucoma	0.000199	0.000413	CcSEcCtD
Imiquimod—Vomiting—Brinzolamide—glaucoma	0.000199	0.000412	CcSEcCtD
Imiquimod—Dizziness—Pilocarpine—glaucoma	0.000198	0.000412	CcSEcCtD
Imiquimod—Headache—Travoprost—glaucoma	0.000198	0.000411	CcSEcCtD
Imiquimod—Nausea—Brimonidine—glaucoma	0.000198	0.00041	CcSEcCtD
Imiquimod—Feeling abnormal—Clonidine—glaucoma	0.000197	0.00041	CcSEcCtD
Imiquimod—Rash—Brinzolamide—glaucoma	0.000197	0.000409	CcSEcCtD
Imiquimod—Dermatitis—Brinzolamide—glaucoma	0.000197	0.000408	CcSEcCtD
Imiquimod—Gastrointestinal pain—Clonidine—glaucoma	0.000196	0.000407	CcSEcCtD
Imiquimod—Headache—Brinzolamide—glaucoma	0.000196	0.000406	CcSEcCtD
Imiquimod—Angioedema—Timolol—glaucoma	0.000191	0.000396	CcSEcCtD
Imiquimod—Vomiting—Pilocarpine—glaucoma	0.000191	0.000396	CcSEcCtD
Imiquimod—Urticaria—Clonidine—glaucoma	0.00019	0.000395	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00019	0.000394	CcSEcCtD
Imiquimod—Abdominal pain—Clonidine—glaucoma	0.000189	0.000393	CcSEcCtD
Imiquimod—Body temperature increased—Clonidine—glaucoma	0.000189	0.000393	CcSEcCtD
Imiquimod—Rash—Pilocarpine—glaucoma	0.000189	0.000393	CcSEcCtD
Imiquimod—Dermatitis—Pilocarpine—glaucoma	0.000189	0.000392	CcSEcCtD
Imiquimod—Insomnia—Betaxolol—glaucoma	0.000189	0.000392	CcSEcCtD
Imiquimod—Nausea—Dorzolamide—glaucoma	0.000189	0.000391	CcSEcCtD
Imiquimod—Headache—Pilocarpine—glaucoma	0.000188	0.00039	CcSEcCtD
Imiquimod—Nausea—Travoprost—glaucoma	0.000188	0.00039	CcSEcCtD
Imiquimod—TLR8—Immune System—IL1A—glaucoma	0.000188	0.00443	CbGpPWpGaD
Imiquimod—Paraesthesia—Betaxolol—glaucoma	0.000187	0.000389	CcSEcCtD
Imiquimod—Syncope—Timolol—glaucoma	0.000187	0.000389	CcSEcCtD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000187	0.00441	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—BAD—glaucoma	0.000186	0.00439	CbGpPWpGaD
Imiquimod—Dyspnoea—Betaxolol—glaucoma	0.000186	0.000386	CcSEcCtD
Imiquimod—Nausea—Brinzolamide—glaucoma	0.000185	0.000385	CcSEcCtD
Imiquimod—Palpitations—Timolol—glaucoma	0.000185	0.000383	CcSEcCtD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000185	0.00436	CbGpPWpGaD
Imiquimod—Dyspepsia—Betaxolol—glaucoma	0.000184	0.000381	CcSEcCtD
Imiquimod—Loss of consciousness—Timolol—glaucoma	0.000184	0.000381	CcSEcCtD
Imiquimod—Cough—Timolol—glaucoma	0.000182	0.000378	CcSEcCtD
Imiquimod—Decreased appetite—Betaxolol—glaucoma	0.000181	0.000376	CcSEcCtD
Imiquimod—Hypertension—Timolol—glaucoma	0.00018	0.000374	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Betaxolol—glaucoma	0.00018	0.000374	CcSEcCtD
Imiquimod—Fatigue—Betaxolol—glaucoma	0.00018	0.000373	CcSEcCtD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000178	0.00421	CbGpPWpGaD
Imiquimod—Pain—Betaxolol—glaucoma	0.000178	0.00037	CcSEcCtD
Imiquimod—Nausea—Pilocarpine—glaucoma	0.000178	0.00037	CcSEcCtD
Imiquimod—Chest pain—Timolol—glaucoma	0.000178	0.000369	CcSEcCtD
Imiquimod—Myalgia—Timolol—glaucoma	0.000178	0.000369	CcSEcCtD
Imiquimod—Arthralgia—Timolol—glaucoma	0.000178	0.000369	CcSEcCtD
Imiquimod—Anxiety—Timolol—glaucoma	0.000177	0.000368	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000177	0.000366	CcSEcCtD
Imiquimod—Hypersensitivity—Clonidine—glaucoma	0.000177	0.000366	CcSEcCtD
Imiquimod—Discomfort—Timolol—glaucoma	0.000176	0.000365	CcSEcCtD
Imiquimod—Dry mouth—Timolol—glaucoma	0.000174	0.000361	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000173	0.00408	CbGpPWpGaD
Imiquimod—Asthenia—Clonidine—glaucoma	0.000172	0.000357	CcSEcCtD
Imiquimod—Feeling abnormal—Betaxolol—glaucoma	0.000172	0.000357	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CDKN1B—glaucoma	0.000171	0.00404	CbGpPWpGaD
Imiquimod—Oedema—Timolol—glaucoma	0.00017	0.000354	CcSEcCtD
Imiquimod—Pruritus—Clonidine—glaucoma	0.00017	0.000352	CcSEcCtD
Imiquimod—Infection—Timolol—glaucoma	0.000169	0.000351	CcSEcCtD
Imiquimod—Shock—Timolol—glaucoma	0.000168	0.000348	CcSEcCtD
Imiquimod—Nervous system disorder—Timolol—glaucoma	0.000167	0.000347	CcSEcCtD
Imiquimod—Urticaria—Betaxolol—glaucoma	0.000166	0.000344	CcSEcCtD
Imiquimod—Skin disorder—Timolol—glaucoma	0.000166	0.000344	CcSEcCtD
Imiquimod—Body temperature increased—Betaxolol—glaucoma	0.000165	0.000342	CcSEcCtD
Imiquimod—TLR8—Immune System—C3—glaucoma	0.000165	0.00389	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Timolol—glaucoma	0.000165	0.000342	CcSEcCtD
Imiquimod—Diarrhoea—Clonidine—glaucoma	0.000164	0.00034	CcSEcCtD
Imiquimod—Anorexia—Timolol—glaucoma	0.000162	0.000337	CcSEcCtD
Imiquimod—Dizziness—Clonidine—glaucoma	0.000158	0.000329	CcSEcCtD
Imiquimod—TLR8—Immune System—BCL2L1—glaucoma	0.000158	0.00372	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Timolol—glaucoma	0.000155	0.000322	CcSEcCtD
Imiquimod—Insomnia—Timolol—glaucoma	0.000154	0.00032	CcSEcCtD
Imiquimod—Hypersensitivity—Betaxolol—glaucoma	0.000154	0.000319	CcSEcCtD
Imiquimod—Paraesthesia—Timolol—glaucoma	0.000153	0.000318	CcSEcCtD
Imiquimod—Vomiting—Clonidine—glaucoma	0.000152	0.000316	CcSEcCtD
Imiquimod—Dyspnoea—Timolol—glaucoma	0.000152	0.000315	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000152	0.00358	CbGpPWpGaD
Imiquimod—Somnolence—Timolol—glaucoma	0.000152	0.000314	CcSEcCtD
Imiquimod—Rash—Clonidine—glaucoma	0.000151	0.000314	CcSEcCtD
Imiquimod—Dermatitis—Clonidine—glaucoma	0.000151	0.000313	CcSEcCtD
Imiquimod—Headache—Clonidine—glaucoma	0.00015	0.000312	CcSEcCtD
Imiquimod—Dyspepsia—Timolol—glaucoma	0.00015	0.000311	CcSEcCtD
Imiquimod—Asthenia—Betaxolol—glaucoma	0.00015	0.000311	CcSEcCtD
Imiquimod—Decreased appetite—Timolol—glaucoma	0.000148	0.000307	CcSEcCtD
Imiquimod—Pruritus—Betaxolol—glaucoma	0.000148	0.000306	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Timolol—glaucoma	0.000147	0.000305	CcSEcCtD
Imiquimod—Fatigue—Timolol—glaucoma	0.000147	0.000305	CcSEcCtD
Imiquimod—Pain—Timolol—glaucoma	0.000146	0.000302	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000144	0.00341	CbGpPWpGaD
Imiquimod—TLR8—Immune System—BAD—glaucoma	0.000143	0.00337	CbGpPWpGaD
Imiquimod—Diarrhoea—Betaxolol—glaucoma	0.000143	0.000296	CcSEcCtD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000142	0.00336	CbGpPWpGaD
Imiquimod—Nausea—Clonidine—glaucoma	0.000142	0.000295	CcSEcCtD
Imiquimod—TLR7—Immune System—IL1A—glaucoma	0.000142	0.00336	CbGpPWpGaD
Imiquimod—Feeling abnormal—Timolol—glaucoma	0.00014	0.000291	CcSEcCtD
Imiquimod—Gastrointestinal pain—Timolol—glaucoma	0.000139	0.000289	CcSEcCtD
Imiquimod—Dizziness—Betaxolol—glaucoma	0.000138	0.000286	CcSEcCtD
Imiquimod—Urticaria—Timolol—glaucoma	0.000135	0.000281	CcSEcCtD
Imiquimod—Abdominal pain—Timolol—glaucoma	0.000135	0.00028	CcSEcCtD
Imiquimod—Body temperature increased—Timolol—glaucoma	0.000135	0.00028	CcSEcCtD
Imiquimod—Vomiting—Betaxolol—glaucoma	0.000133	0.000275	CcSEcCtD
Imiquimod—Rash—Betaxolol—glaucoma	0.000132	0.000273	CcSEcCtD
Imiquimod—Dermatitis—Betaxolol—glaucoma	0.000131	0.000273	CcSEcCtD
Imiquimod—Headache—Betaxolol—glaucoma	0.000131	0.000271	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CDKN1B—glaucoma	0.00013	0.00306	CbGpPWpGaD
Imiquimod—Hypersensitivity—Timolol—glaucoma	0.000126	0.000261	CcSEcCtD
Imiquimod—TLR7—Immune System—C3—glaucoma	0.000125	0.00295	CbGpPWpGaD
Imiquimod—Nausea—Betaxolol—glaucoma	0.000124	0.000257	CcSEcCtD
Imiquimod—Asthenia—Timolol—glaucoma	0.000122	0.000254	CcSEcCtD
Imiquimod—Pruritus—Timolol—glaucoma	0.000121	0.00025	CcSEcCtD
Imiquimod—TLR7—Immune System—BCL2L1—glaucoma	0.00012	0.00282	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000117	0.00276	CbGpPWpGaD
Imiquimod—Diarrhoea—Timolol—glaucoma	0.000117	0.000242	CcSEcCtD
Imiquimod—Dizziness—Timolol—glaucoma	0.000113	0.000234	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.00011	0.0026	CbGpPWpGaD
Imiquimod—Vomiting—Timolol—glaucoma	0.000108	0.000225	CcSEcCtD
Imiquimod—TLR7—Immune System—BAD—glaucoma	0.000108	0.00256	CbGpPWpGaD
Imiquimod—Rash—Timolol—glaucoma	0.000107	0.000223	CcSEcCtD
Imiquimod—Dermatitis—Timolol—glaucoma	0.000107	0.000223	CcSEcCtD
Imiquimod—Headache—Timolol—glaucoma	0.000107	0.000222	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000104	0.00246	CbGpPWpGaD
Imiquimod—Nausea—Timolol—glaucoma	0.000101	0.00021	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000101	0.00239	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CDKN1B—glaucoma	9.96e-05	0.00235	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	9.87e-05	0.00233	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	9.87e-05	0.00233	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	9.75e-05	0.0023	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	8.21e-05	0.00194	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP1B1—glaucoma	8.05e-05	0.0019	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	7.94e-05	0.00187	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.8e-05	0.00184	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDKN1B—glaucoma	7.55e-05	0.00178	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.52e-05	0.00178	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NARFL—glaucoma	7.08e-05	0.00167	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA5A—glaucoma	7.08e-05	0.00167	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	7.04e-05	0.00166	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	7.04e-05	0.00166	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTM1—glaucoma	6.44e-05	0.00152	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	6.35e-05	0.0015	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.21e-05	0.00147	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.13e-05	0.00145	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NARFL—glaucoma	5.47e-05	0.00129	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA5A—glaucoma	5.47e-05	0.00129	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.97e-05	0.00117	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.9e-05	0.00116	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA1—glaucoma	3.46e-05	0.000816	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CTSA—glaucoma	3.35e-05	0.000791	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA2—glaucoma	3.16e-05	0.000747	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.09e-05	0.00073	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.09e-05	0.00073	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA1—glaucoma	2.67e-05	0.00063	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CTSA—glaucoma	2.59e-05	0.00061	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA2—glaucoma	2.44e-05	0.000576	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TXN—glaucoma	2.23e-05	0.000526	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.03e-05	0.00048	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.01e-05	0.000476	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTT1—glaucoma	1.73e-05	0.000408	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TXN—glaucoma	1.72e-05	0.000406	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.39e-05	0.000329	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCA1—glaucoma	1.38e-05	0.000325	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP1B1—glaucoma	1.38e-05	0.000325	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTT1—glaucoma	1.33e-05	0.000315	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—glaucoma	1.1e-05	0.00026	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCA1—glaucoma	1.06e-05	0.000251	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1B1—glaucoma	1.06e-05	0.000251	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—glaucoma	9.73e-06	0.00023	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOE—glaucoma	9.06e-06	0.000214	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CAV1—glaucoma	8.97e-06	0.000212	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—glaucoma	8.49e-06	0.000201	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—glaucoma	7.51e-06	0.000177	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOE—glaucoma	6.99e-06	0.000165	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CAV1—glaucoma	6.93e-06	0.000163	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—glaucoma	6.78e-06	0.00016	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—glaucoma	6.21e-06	0.000146	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—glaucoma	5.24e-06	0.000124	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—glaucoma	4.79e-06	0.000113	CbGpPWpGaD
